Benign prostatic hyperplasia affects over 500 million men worldwide. While men can select from a variety of treatment options-from medication to major surgery-there has been a gap in the treatment continuum for a less invasive option. The UroLift System uses a revolutionary approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. It is the only transurethral BPH treatment that does not require ongoing medication, heating, cutting or removal of the prostate tissue. Treatment with the UroLift System typically takes less than one hour and does not preclude future UroLift System treatments, TURP, or laser procedures.